Search

Your search keyword '"Prior, D"' showing total 998 results

Search Constraints

Start Over You searched for: Author "Prior, D" Remove constraint Author: "Prior, D"
998 results on '"Prior, D"'

Search Results

1. A HISTORICAL PAPER.

2. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

3. Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis

5. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

7. Multidisciplinary team discussion: the emerging gold standard for management of cardiopulmonary complications of connective tissue disease

8. Disease specific determinants of cardiopulmonary fitness in systemic sclerosis

9. SIAEF/PoE: Accountability of Earnestness for encoding subjective information in Blockchain

10. Reinforcement Learning-Based News Recommendation System

14. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

20. Characteristics and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction Compared to Heart Failure With Reduced Ejection Fraction: Insights From the VCOR Heart Failure Snapshot.

21. Management of Acute Decompensated Heart Failure in Rural vs Metropolitan Settings: A Victorian Experience.

22. Myocardial fibrosis and arrhythmic burden in systemic sclerosis

23. Clinical risk prediction model for 30-day all-cause re-hospitalisation or mortality in patients hospitalised with heart failure

24. Characteristics and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction Compared to Heart Failure With Reduced Ejection Fraction: Insights From the VCOR Heart Failure Snapshot

25. Proof by Earnestness (PoE) to determine the authenticity of subjective information in blockchains - application in supply chain risk management

26. Can changes in deformation regimes be inferred from crystallographic preferred orientations in polar ice?

27. Plastic Faulting in Ice

28. Full-field numerical simulations of ice viscoplastic deformation during two deformation events

30. Clinical risk prediction model for 30-day all-cause re-hospitalisation or mortality in patients hospitalised with heart failure

32. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

35. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

39. Making EBSD on water ice routine

44. Ice-sheet flow transitions: for how long can crystallographic preferred orientations be preserved?

45. Insights into seismic anisotropy of temperate ice in basal ice sheet conditions

46. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study

47. Management of Acute Decompensated Heart Failure in Rural Versus Metropolitan Settings: An Australian Experience.

48. Characteristics and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction Compared to Heart Failure With Reduced Ejection Fraction: Insights From the VCOR Heart Failure Snapshot.

49. Ejection fraction and mortality: a nationwide register-based cohort study of 499 153 women and men.

50. Diastolic dysfunction and mortality in 436 360 men and women: the National Echo Database Australia (NEDA)

Catalog

Books, media, physical & digital resources